Doctor profile · Federal record
Dr. Philip Lieu, M.D.
Ophthalmology Physician (CMS: Ophthalmology) · Ophthalmology Physician · Ophthalmology Physician · Desoto, TX
- NPI 1164740718
- Accepts Medicare
- 16 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
2625 Bolton Boone Dr
Desoto, TX 751152011
(972) 283-1516
fax (972) 283-1448 - Additional location
-
1000 Wall Street
Ann Arbor, MI 481051912
(734) 764-4190 - Additional location
-
3181 E Grand Blanc Road
Grand Blanc, MI 48439
(810) 694-6933
Credentials & registration
- NPI registered
- May 2010 — 16 yrs on file
- Profile last updated
- July 30, 2020
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State licenses (3)
- Texas #S4807 · Michigan #4301104568 · Texas #BP20040314
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1164740718. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
13,209
Distinct HCPCS
10
Medicare allowed
$1,349,462
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 8,700 | 46 | $36 | |
92134 |
Imaging of retina | 1,120 | 444 | $40 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 956 | 54 | $273 | |
67028 |
Injection of drug into eye | 677 | 155 | $120 | |
J0178 |
Injection, aflibercept, 1 mg | 488 | 53 | $867 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 333 | 255 | $124 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 274 | 274 | $163 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 185 | 19 | $232 | |
92250 |
Photography of the retina | 142 | 139 | $37 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 130 | 68 | $89 |
In context: peer comparison
Among 4 peers in Desoto Ophthalmology Physician, average services per provider: 986. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$3,810
Transactions
20
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genentech USA, INC. | 2 | $2,137.16 | |
| Beaver-Visitec International, INC. | 1 | $1,200.00 | |
| Ani Pharmaceuticals, INC. | 5 | $140.28 | |
| Regeneron Healthcare Solutions, INC. | 3 | $90.01 | |
| Astellas Pharma US INC | 3 | $83.64 | |
| Sandoz INC. | 3 | $78.57 | |
| Harrow Eye, LLC | 1 | $28.52 | |
| Abbvie INC. | 1 | $27.30 | |
| Apellis Pharmaceuticals, INC. | 1 | $24.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
569
Patients
331
Total drug cost
$17,439
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 197 | 146 | $2,751 |
| Prednisolone Acetate | Generic | 96 | 55 | $3,975 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 78 | 40 | $1,617 |
| Brimonidine Tartrate | Generic | 32 | 20 | $619 |
| Erythromycin (Erythromycin Base) | Brand | 27 | 21 | $288 |
| Timolol Maleate | Generic | 26 | 13 | $217 |
| Latanoprost | Generic | 25 | 11 | $1,078 |
| Diclofenac Sodium | Generic | 24 | 13 | $256 |
| Difluprednate | Generic | 20 | 12 | $3,021 |
| Atropine Sulfate | Generic | 16 | 0 | $807 |
Frequently asked questions
What is Dr. Philip Lieu's medical specialty?
Dr. Philip Lieu practices Ophthalmology Physician in Desoto, TX.
Where does Dr. Philip Lieu practice?
Dr. Philip Lieu practices at 2625 Bolton Boone Dr, Desoto, TX 751152011. Office phone: 9722831516.
What is Dr. Philip Lieu's NPI?
Dr. Philip Lieu's National Provider Identifier (NPI) is 1164740718, issued by NPPES.
Does Dr. Philip Lieu accept Medicare assignment?
Yes. Dr. Philip Lieu accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Philip Lieu commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Imaging of retina (HCPCS 92134); Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg (HCPCS Q5128). Source: CMS Medicare Physician & Other Practitioners file.